CenterBook Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.46M | Sell |
14,353
-12,301
| -46% | -$2.97M | 0.19% | 139 |
|
|
2025
Q1 | $6.49M | Buy |
26,654
+14,835
| +126% | +$3.61M | 0.41% | 65 |
|
|
2024
Q4 | $3.88M | Buy |
11,819
+7,635
| +182% | +$2.51M | 0.23% | 128 |
|
|
2024
Q3 | $1.4M | Sell |
4,184
-11,902
| -74% | -$3.98M | 0.09% | 254 |
|
|
2024
Q2 | $4.39M | Buy |
16,086
+1,199
| +8% | +$327K | 0.27% | 135 |
|
|
2024
Q1 | $5.15M | Buy |
14,887
+4,833
| +48% | +$1.67M | 0.36% | 96 |
|
|
2023
Q4 | $3.25M | Buy |
10,054
+3,039
| +43% | +$981K | 0.4% | 70 |
|
|
2023
Q3 | $2.51M | Sell |
7,015
-6,224
| -47% | -$2.23M | 0.31% | 98 |
|
|
2023
Q2 | $5.02M | Buy |
13,239
+10,386
| +364% | +$3.94M | 0.63% | 26 |
|
|
2023
Q1 | $1.37M | Sell |
2,853
-2,430
| -46% | -$1.16M | 0.19% | 173 |
|
|
2022
Q4 | $2.22M | Buy |
5,283
+3,363
| +175% | +$1.41M | 0.37% | 84 |
|
|
2022
Q3 | $801K | Sell |
1,920
-159
| -8% | -$66.3K | 0.15% | 222 |
|
|
2022
Q2 | $1.03M | Buy |
+2,079
| New | +$1.03M | 0.22% | 166 |
|